Use of peripheral perfusion index (PI) as a predictor of cardiovascular complications in hospitalised Covid 19 patients - A pilot study
-
Published:2022-11-14
Issue:5
Volume:42
Page:1008-1013
-
ISSN:0970-2067
-
Container-title:Biomedicine
-
language:
-
Short-container-title:Biomedicine
Author:
Menon Aparna,R. Divya
Abstract
Introduction and Aim: Cardiovascular complications have been associated with fatality in Covid-19 patients. Reduced peripheral perfusion is a marker for cardiovascular dysfunction. Peripheral Perfusion Index (PI) is a non-invasive measure of microvascular perfusion with regards to pulsatile arterial blood flow. The study was aimed at finding the utility of PI as a hemodynamic marker in Covid-19.
Materials and Methods: Observational study done on 58 hospitalised adult Covid-19 patients over a span of 6 days. Each day the hemodynamic parameters such as pulse rate, SpO2 and Peripheral Perfusion Index (PI) were measured using a finger pulse oximeter. Peripheral Blood pressure was measured using automated BP apparatus. Mean Arterial Pressure (MAP) and pulse pressure (PP) was calculated.
Results: Correlation between PI and other parameters checked using Pearson’s test. There was significant positive correlation between PI and PP in day wise analysis during first 2 days with linear regression showing PP can be predicted as a dependant function from PI. This shows the association between PI and systemic cardiovascular function.
Conclusion: PI is a useful measure of peripheral microvascular perfusion and relates to systemic PP. It can be predicted from the results that PI can act as a reliable guide to predict the cardiovascular condition of the patient. As PI is measured from finger pulse oximeter, it is a non-invasive and easy-to-record method, which can be used by untrained personnel in Covid-19 patients.
Publisher
Indian Association of Biomedical Scientists
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference26 articles.
1. WHO. Covid 19 pandemic. Available from: https://www.mohfw.gov.in/[Accessed:2022/01/14] 2. MoHFW. Home. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed:2022/01/14] 3. Panagides, V., Vincent, F., Weizman, O., Jonveaux, M., Trimaille, A., Pommier, T., et al., History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis., 2021; 114(5): 415-425. 4. Harrison, S, L., Buckley, B.J.R., Rivera-caravaca, M., Zhang, J., Lip, G.Y.H. OUP accepted manuscript. Eur Hear J - Qual Care Clin Outcomes. 2021; 1-10. 5. Boerma, E. C., Bethlehem, C., Stellingwerf, F., De Lange, F., Streng, K.W., Koetsier, P.M., et al., Hemodynamic characteristics of mechanically ventilated covid-19 patients: A Cohort Analysis. Crit Care Res Pract. 2021; 2021:1-7
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|